International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 5 , Pages 1303-1308 , 1 August 2010

Reduction in Radiation-Induced Morbidity by Use of an Intercurrent Boost in the Management of Early-Stage Breast Cancer

  • Mark Trombetta, M.D.

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • Drexel University College of Medicine, Allegheny Campus, Pittsburgh, PA
    • Corresponding Author InformationReprint requests to: Mark Trombetta, M.D., Department of Radiation Oncology, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212. Tel: (412) 359-3400; Fax: (412) 359-3981
    • ,
  • Thomas B. Julian, M.D.

      Affiliations

    • Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA
    • Drexel University College of Medicine, Allegheny Campus, Pittsburgh, PA
    • ,
  • Vladimir Valakh, M.D.

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • ,
  • Larisa Greenberg, M.D.

      Affiliations

    • Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA
    • Drexel University College of Medicine, Allegheny Campus, Pittsburgh, PA
    • ,
  • George Labban, M.D.

      Affiliations

    • Division of Hematology-Oncology, Western Pennsylvania Hospital, Pittsburgh, PA
    • ,
  • Mian K. Khalid, M.D.

      Affiliations

    • Division of Hematology-Oncology, Western Pennsylvania Hospital, Pittsburgh, PA
    • ,
  • E. Day Werts, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • Drexel University College of Medicine, Allegheny Campus, Pittsburgh, PA
    • ,
  • David Parda, M.D.

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • Drexel University College of Medicine, Allegheny Campus, Pittsburgh, PA

Received 5 May 2009 ,Revised 25 June 2009 ,Accepted 27 June 2009.

References 

  1. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312:665–673
  2. Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Eng J Med. 1981;305:6–11
  3. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–1232
  4. Polgar C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma—5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694–702
  5. Morrow M. Rational local therapy for breast cancer. N Engl J Med. 2002;347:1270–1271
  6. Benitez P, Chen P, Vicini F, et al. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy. Am J Surg. 2004;188:355–364
  7. Recht A, Silver B, Schnitt S, et al. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys. 1985;11:1271–1276
  8. King T, Bolton J, Kuske R, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg. 2000;180:299–304
  9. Vicini F, Baglan K, Kestin L, et al. The emerging role of brachytherapy in the management of patients with breast cancer. Semin Radiat Oncol. 2002;12:31–39
  10. Baglan K, Sharpe M, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (#D-CRT). Int J Radiat Oncol Biol Phys. 2003;55:302–311
  11. NSABP B-32: Phase III Randomized Trial Comparing Axillary Resection with Sentinel Lymph Node Dissection: A Description of the Trial. Ann Surg Oncol. 2004;11:208S–210S
  12. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0 (DCTD, NCI, NIH, DHHS; March 31, 2003). August 9, 2006. Available at http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3to2.pdf. Accessed July 7, 2010.
  13. Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Eng J Med. 2001;345:1378–1387
  14. Fortin A, Larochelle M, Laverdière J, et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol. 1999;17:101–109
  15. Brooks J, Danforth D, Albert P, et al. Early ipsilateral breast tumor recurrences after breast conservation affect survival: An analysis of the National Cancer Institute randomized trial. Int J Radiat Oncol Biol Phys. 2005;62:785–789
  16. Early Breast Cancer Trialists Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087–2106
  17. Arthur DW, Cuttino LW, Neuschatz AC, et al. Tumor bed boost omission after negative re-excision in breast conservation treatment. Ann Surg Oncol. 2006;13:794–801
  18. Julian TB, Land SR, Wang y, et al. Is boost therapy necessary in the treatment of DCIS?. J Clin Oncol. 2008;26(Suppl):537
  19. Clark RM, Wilkinson R, Miceli P, et al. Breast cancer: Experiences with conservation therapy. Am J Clin Oncol. 1987;10:461–468
  20. Fisher E, Sass R, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6) II. Relation of local breast recurrence to multicentricity. Cancer. 1986;57:1717–1724
  21. Lopez E, Nuñez MI, Guerrero MR, et al. Breast cancer acute morbidity evaluated by different scoring systems. Breast Cancer Res Treat. 2002;73:127–134
  22. Harper JL, Franklin L, Jenrette J, et al. Skin toxicity during breast irradiation: Pathophysiology and management. South Med J. 2004;97:989–993
  23. Freedman GM, Anderson P, Li J, et al. Intensity modulated radiation therapy decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol. 2006;29:66–70
  24. Bostrom A. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: Results from a double blind study. Radiother Oncol. 2002;59:257–265
  25. Farhan F, Kazemian A, Alagheband H. Topical betamethasone for the prevention of acute radiation dermatitis in breast cancer patients. Iran J Radiat Res. 2003;1:105–111
  26. Potera M. Prophylaxis of radiation dermatitis with a topical cortisone cream. Radiology. 1982;143:775–777
  27. Schmuth M, Wimmer M, Hofer S. Topical corticosteroid therapy for acute radiation dermatitis: A prospective, randomized, double-blind study. BJD. 2002;146:983–991
  28. Taylor M, Perez CE, Halverson K, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 1995;31:753–764
  29. Gorodetsky R, Lotan C, Piggot K, et al. Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy. Int J Radiat Oncol Biol Phys. 1999;45:893–900

 Conflict of interest: none.

PII: S0360-3016(09)01001-3

doi: 10.1016/j.ijrobp.2009.06.056

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 5 , Pages 1303-1308 , 1 August 2010

Article Tools

* Image Usage & Resolution